Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. COMP360 is most often covered alongside Compass Pathways, which appears in 1 of these 1 story. Their average consequence score of 5 runs below the beat's 5.8 for that window.
Last mentioned: Mar 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. COMP360 is most often covered alongside Compass Pathways, which appears in 1 of these 1 story. Their average consequence score of 5 runs below the beat's 5.8 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. COMP360 appears in 1 tracked Healthcare story from March 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering COMP360. Shared-story counts are live from our verified record — not editorial picks.
Anticipated Data Readout
Expected primary endpoint results for the COMP005 Phase 3 trial in TRD.
Fiscal Year End
Closed 2025 with a strategic focus on regulatory filing preparations.
Therapist Training Milestone
Completed training for over 500 facilitators to support Phase 3 delivery protocols.
Phase 3 Expansion
Compass increased the number of active clinical sites for COMP006 to over 50 globally.
Compass Pathways reported its full-year 2025 financial results, highlighting a strategic focus on its pivotal Phase 3 COMP360 program for treatment-resistant depression. With a cash runway extending into late 2026, the company is positioned for a critical year of clinical readouts and regulatory engagement.
Source: finanznachrichten.de · pharmiweb.com
COMP360 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
